Charles E. Dean
The Skeptical Professional's Guide to Psychiatry (eBook, PDF)
On the Risks and Benefits of Antipsychotics, Antidepressants, Psychiatric Diagnoses, and Neuromania
40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
20 °P sammeln
40,95 €
Als Download kaufen
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
20 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
20 °P sammeln
Charles E. Dean
The Skeptical Professional's Guide to Psychiatry (eBook, PDF)
On the Risks and Benefits of Antipsychotics, Antidepressants, Psychiatric Diagnoses, and Neuromania
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This text critically examines the shortcomings of psychiatry, the flawed development of the diagnostic system, including the DSM-5, and the failure to advance the effectiveness of antipsychotics and antidepressants.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 2.91MB
This text critically examines the shortcomings of psychiatry, the flawed development of the diagnostic system, including the DSM-5, and the failure to advance the effectiveness of antipsychotics and antidepressants.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 348
- Erscheinungstermin: 22. November 2020
- Englisch
- ISBN-13: 9781000245585
- Artikelnr.: 60439613
- Verlag: Taylor & Francis
- Seitenzahl: 348
- Erscheinungstermin: 22. November 2020
- Englisch
- ISBN-13: 9781000245585
- Artikelnr.: 60439613
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Charles E. Dean, M.D., has 47 years of clinical, educational, and research experience. He has taught psychopharmacology and clinical neuroscience at the Minneapolis VA Medical Center and the University of Minnesota.
List of Abbreviations; Permissions; Introduction; Chapter 1. The Biological
Revolution in Psychiatry: An Overview of the Dark Ages; Chapter 2. The
Biological Revolution: The Middle Years and the Rise of Psychopharmacology;
Chapter 3. Has the Biological Revolution Delivered? A Focus on
Antipsychotics; Chapter 4. Antipsychotics and the Metabolic Syndrome,
Cardiovascular Disease, and Mortality; Chapter 5. Antipsychotics and
Mortality in the Elderly with Dementia; Chapter 6. Psychotropic and
Antipsychotic Polypharmacy: Common Practice, Good Medicine?; Chapter 7. The
Neurologic Consequences of Antipsychotics: From Parkinsonism to Tardive
Dyskinesia; Chapter 8. Antidepressants and Depression: Background and
Biology; Chapter 9. Antidepressants: Do They Work? If So, When, How Often,
and at What Costs?; Chapter 10. Antidepressants and Adverse Events: Falls
and Fractures, Vascular Events, Risks in Pregnancy, and Abnormal Movements;
Chapter 11. Treatment-Resistant Depression: Combining and Switching
Antidepressants, Adding Antipsychotics, and On to Neurotherapeutics;
Chapter 12. Desperately Treating Depression: On Psychotogenic and
Hallucinogenic Drugs, Anti-Inflammatories, Antidiabetics, Hyperthermia, and
Opioids; Chapter 13. Psychiatric Diagnoses: The DSM and the Roots of
Failure; Chapter 14. Fear and Loathing at the APA: The DSM-5, The Brain
Mapping Quartet, and the Future of Mental Illness; Index.
Revolution in Psychiatry: An Overview of the Dark Ages; Chapter 2. The
Biological Revolution: The Middle Years and the Rise of Psychopharmacology;
Chapter 3. Has the Biological Revolution Delivered? A Focus on
Antipsychotics; Chapter 4. Antipsychotics and the Metabolic Syndrome,
Cardiovascular Disease, and Mortality; Chapter 5. Antipsychotics and
Mortality in the Elderly with Dementia; Chapter 6. Psychotropic and
Antipsychotic Polypharmacy: Common Practice, Good Medicine?; Chapter 7. The
Neurologic Consequences of Antipsychotics: From Parkinsonism to Tardive
Dyskinesia; Chapter 8. Antidepressants and Depression: Background and
Biology; Chapter 9. Antidepressants: Do They Work? If So, When, How Often,
and at What Costs?; Chapter 10. Antidepressants and Adverse Events: Falls
and Fractures, Vascular Events, Risks in Pregnancy, and Abnormal Movements;
Chapter 11. Treatment-Resistant Depression: Combining and Switching
Antidepressants, Adding Antipsychotics, and On to Neurotherapeutics;
Chapter 12. Desperately Treating Depression: On Psychotogenic and
Hallucinogenic Drugs, Anti-Inflammatories, Antidiabetics, Hyperthermia, and
Opioids; Chapter 13. Psychiatric Diagnoses: The DSM and the Roots of
Failure; Chapter 14. Fear and Loathing at the APA: The DSM-5, The Brain
Mapping Quartet, and the Future of Mental Illness; Index.
List of Abbreviations; Permissions; Introduction; Chapter 1. The Biological
Revolution in Psychiatry: An Overview of the Dark Ages; Chapter 2. The
Biological Revolution: The Middle Years and the Rise of Psychopharmacology;
Chapter 3. Has the Biological Revolution Delivered? A Focus on
Antipsychotics; Chapter 4. Antipsychotics and the Metabolic Syndrome,
Cardiovascular Disease, and Mortality; Chapter 5. Antipsychotics and
Mortality in the Elderly with Dementia; Chapter 6. Psychotropic and
Antipsychotic Polypharmacy: Common Practice, Good Medicine?; Chapter 7. The
Neurologic Consequences of Antipsychotics: From Parkinsonism to Tardive
Dyskinesia; Chapter 8. Antidepressants and Depression: Background and
Biology; Chapter 9. Antidepressants: Do They Work? If So, When, How Often,
and at What Costs?; Chapter 10. Antidepressants and Adverse Events: Falls
and Fractures, Vascular Events, Risks in Pregnancy, and Abnormal Movements;
Chapter 11. Treatment-Resistant Depression: Combining and Switching
Antidepressants, Adding Antipsychotics, and On to Neurotherapeutics;
Chapter 12. Desperately Treating Depression: On Psychotogenic and
Hallucinogenic Drugs, Anti-Inflammatories, Antidiabetics, Hyperthermia, and
Opioids; Chapter 13. Psychiatric Diagnoses: The DSM and the Roots of
Failure; Chapter 14. Fear and Loathing at the APA: The DSM-5, The Brain
Mapping Quartet, and the Future of Mental Illness; Index.
Revolution in Psychiatry: An Overview of the Dark Ages; Chapter 2. The
Biological Revolution: The Middle Years and the Rise of Psychopharmacology;
Chapter 3. Has the Biological Revolution Delivered? A Focus on
Antipsychotics; Chapter 4. Antipsychotics and the Metabolic Syndrome,
Cardiovascular Disease, and Mortality; Chapter 5. Antipsychotics and
Mortality in the Elderly with Dementia; Chapter 6. Psychotropic and
Antipsychotic Polypharmacy: Common Practice, Good Medicine?; Chapter 7. The
Neurologic Consequences of Antipsychotics: From Parkinsonism to Tardive
Dyskinesia; Chapter 8. Antidepressants and Depression: Background and
Biology; Chapter 9. Antidepressants: Do They Work? If So, When, How Often,
and at What Costs?; Chapter 10. Antidepressants and Adverse Events: Falls
and Fractures, Vascular Events, Risks in Pregnancy, and Abnormal Movements;
Chapter 11. Treatment-Resistant Depression: Combining and Switching
Antidepressants, Adding Antipsychotics, and On to Neurotherapeutics;
Chapter 12. Desperately Treating Depression: On Psychotogenic and
Hallucinogenic Drugs, Anti-Inflammatories, Antidiabetics, Hyperthermia, and
Opioids; Chapter 13. Psychiatric Diagnoses: The DSM and the Roots of
Failure; Chapter 14. Fear and Loathing at the APA: The DSM-5, The Brain
Mapping Quartet, and the Future of Mental Illness; Index.